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A b s t r a c t
Introduction: Safety of dental extractions in patients on chronic antiplatelet therapy either with only acetylsalicylic acid (ASA) 
or clopidogrel or with both combined has been a matter of debate, with no clearly conclusive studies published. 
Aim: To perform a meta-analysis of published observational studies in order to study the effect of single and double antiplatelet 
therapy in comparison to controls on the occurrence of immediate local bleeding complications during dental extractions.
Material and methods: PubMed/Scopus/Embase database search revealed 22 papers (13 original and 9 review), 3 of which 
were finally included in the meta-analysis. Phrases searched: dual[All Fields] AND antiplatelet[All Fields] AND (“therapy”[Subhead-
ing] OR “therapy”[All Fields] OR “therapeutics”[MeSH Terms] OR “therapeutics”[All Fields]) AND (“tooth extraction”[MeSH Terms] OR 
(“tooth”[All Fields] AND “extraction”[All Fields]) OR “tooth extraction”[All Fields]). 
Results: The overall event incidence (bleeding complication after extraction) in the entire population was 1.59% (42 events in 
2637 patients). As compared to the control group, the use of double antiplatelet therapy DAPT was associated with on odd ratio OR 
of 40.23 (95% CI: 4.37–370.36) increase in risk of bleeding events occurrence (p = 0.0011). Significant heterogeneity was observed 
(p < 0.001; I2 of 76.7%). 
Conclusions: Dental extractions following strict procedural protocols in patients on double antiplatelet therapy with clopidogrel 
and ASA are associated with an additional risk of immediate local bleeding complications.
Key words: tooth extraction, cardiovascular diseases, platelet aggregation.
S u m m a r y
This is the first meta-analysis based on strict enrollment and outcome definition criteria in order to select only homoge-
neous studies and investigating immediate bleeding complications after dental extractions in patients on single (SAPT) or dou-
ble (DAPT) antiplatelet therapy. Although the majority of studies report no excess bleeding on DAPT, we have proven that when 
pooling these data there is an increased risk of immediate bleeding, especially on acetylsalicylic acid and clopidogrel therapy.
Introduction
The management of dental extractions in patients 
on single (SAPT) or double antiplatelet therapy (DAPT) by 
dentists has raised major concerns since these therapies 
have become more widely used among patients after 
percutaneous coronary interventions. The number of pa-
tients receiving antiplatelet therapies is increasing annu-
ally [1]. The duration of these therapies for individual pa-
Michał Zabojszcz et al. Dental extractions in patients on DAPT
69Advances in Interventional Cardiology 2019; 15, 1 (55)
tients varies but is usually between 1 and 12 months for 
DAPT and sometimes lifelong for SAPT [2]. Moreover, new 
generations of more potent antiplatelet drugs have been 
introduced onto the market and recommended by the 
European Society of Cardiology (ESC) guidelines [2, 3]. 
The fear of potential bleeding risk during tooth extraction 
has been weighed against the fear of acute stent throm-
bosis, which is strongly linked to discontinuation of DAPT 
and may become fatal [4].
Safety of dental extractions in patients on chronic 
antiplatelet therapy either with only acetylsalicylic acid 
(ASA) or clopidogrel or with both combined has been 
a matter of debate for some time [5]. No clearly conclu-
sive studies have been published either way, mainly due 
to low sample size. However, the results of the majority 
of them have proven the safety of dental extractions in 
the setting of antiplatelet drugs in comparison to naïve 
patients [6]. Unfortunately, only observational studies are 
available since no randomized clinical trials have been 
conducted.
In 2016 a position paper of cardiologists and dentists 
was published, which encourages maintaining single or 
double antiplatelet therapy in patients undergoing small 
surgical dental procedures [7]. The consensus advocates 
that management in such clinical scenarios should follow 
the scarce evidence that has been provided so far rather 
than putting patients at risk of cardiovascular events.
Aim
The aim of this paper was to perform a meta-anal-
ysis of published observational studies that met specif-
ic inclusion/exclusion criteria as described in the PICO 
Scheme below in order to study the effect of single and 
double antiplatelet therapy in comparison to controls on 
the occurrence of immediate local bleeding complica-
tions during dental extractions.
Material and methods
A systematic review and meta-analysis was conduct-
ed in order to answer the following focused question: 
“Do patients on antiplatelet therapy (single or dual) who 
undergo dental extractions without discontinuation of 
treatment when compared with healthy subjects experi-
ence more post-extraction bleeding complications?”
The following PICO scheme was applied.
Population
Inclusion criteria: Patients with dual antiplatelet ther-
apy (ASA and clopidogrel) or single antiplatelet therapy 
(ASA or clopidogrel) during tooth/teeth extraction who 
did not terminate or withheld their treatment for the ex-
traction procedure.
Exclusion criteria: Liver disease, alcoholism, current 
anticoagulant therapy, current non-steroidal anti-inflam-
matory drugs (NSAID) therapy or any chronic disease 
that could impact bleeding after extraction. Patients on 
ticlopidine (not recommended by the ESC guidelines) 
and prasugrel (only 2 patients in the entire meta-analysis 
population) and ticagrelor (no patients) were excluded 
from the analysis. 
Intervention
Simple tooth/teeth extractions (without raising a mu-
coperiosteal flap) with the use of local anesthesia which 
treated primarily with local hemostatic measures that are 
usually applied by dentists (bite on a pressure gauze pad 
and/or placement of local hemostatic agent such as ox-
idative cellulose gauze, collagen or gelatin sponge, etc.) 
Controls
Patients with no antiplatelet therapy at the time of 
dental extraction.
Outcome
Postoperative bleeding event occurrence as defined 
by Lockhart et al. or based on this definition [8]. Pro-
longed immediate bleeding was defined as the need to 
use hemostatic gauze when blood extended beyond the 
tooth socket after 30 min of biting on a pressure pack. 
Studies where only VAS (Visual Assessment Scale) for 
bleeding severity was used were not included.
On May 3rd 2018 a PubMed, Scopus and EMBASE da-
tabase search with no time-of-publication limits was per-
formed. The search was conducted independently by two 
investigators. In case of any discrepancies the committee 
was organized with a  third member to minimize selec-
tion bias. We used the following English phrases:
• dual[All Fields] AND antiplatelet[All Fields] AND 
(“therapy”[Subheading] OR “therapy”[All Fields] OR 
“therapeutics”[MeSH Terms] OR “therapeutics”[All 
Fields]) AND (“tooth extraction”[MeSH Terms] OR 
(“tooth”[All Fields] AND “extraction”[All Fields]) OR 
“tooth extraction”[All Fields]) and
• dual[All Fields] AND antiplatelet[All Fields] AND (“ther-
apy”[Subheading] OR “therapy”[All Fields] OR “thera-
peutics”[MeSH Terms] OR “therapeutics”[All Fields]) 
AND (“tooth extraction”[MeSH Terms] OR (“tooth”[All 
Fields] AND “extraction”[All Fields]) OR “tooth ex-
traction”[All Fields] OR (“dental”[All Fields] AND “ex-
traction”[All Fields]) OR “dental extraction”[All Fields]).
We also searched the database with the additional 
words “aspirin”, “clopidogrel”, “prasugrel” and “ticagre-
lor” in the search phrase instead of “dual antiplatelet 
therapy” so as to extract all possible publications.
Due to the established strict PICO definition, for in-
clusion in the analysis, only papers which fulfilled patient 
inclusion and exclusion criteria as well as outcome mea-
sures described below were finally considered suitable 
to be used in qualitative and quantitative analysis. Only 
studies with all intergroup comparisons (DAPT, SAPT with 
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ASA, SAPT with clopidogrel, controls) were included in the 
analysis. The above-mentioned process is also presented 
in the PRISMA flowchart (Figure 1). The risk of individ-
ual study bias was minimized due to strict study selec-
tion criteria and similarity of populations and outcome 
measurements in studies. Patients selection in all studies 
was based on consecutive patient (prospective or retro-
spective) enrollment. No external funding was used to 
perform this meta-analysis. All three studies entered into 
meta-analysis were approved by local bioethics commit-
tees. External funding was only reported for the Lu et al. 
study, which was supported in part by a CMRP research 
grant from the Chang Gung Memorial Hospital, Kaohsi-
ung, Taiwan (CMRPG8C0642) [9].
Statistical analysis
For each arm of all 3 trials the number of patients 
who experienced bleeding was collected as well as the 
total number of patients. The summary for all patients 
with bleeding events was presented as a percentage. The 
standard errors from arm-based data were transformed 
into standard errors for pairwise comparisons and the 
percentages were recalculated into odds ratios with the 
control as a reference group. Each of the considered trials 
presented results for each of the considered arms (SAPT 
with ASA, SAPT with clopidogrel, DAPT and control); 
hence all comparisons were direct head-to-head com-
parisons. The similarity of selected trials was assured 
with the detailed PICO scheme that allowed application 
of rigorous criteria to study population, design, outcome 
measures as well as patients’ characteristics and treat-
ment – well known effect modifiers. Heterogeneity was 
assessed using Cochrane’s Q; the percentage of varia-
tion across studies due to heterogeneity rather than 
chance was expressed using the I2 statistic. Random or 
fixed arm-based models were calculated depending on 
observed heterogeneity. Results were presented both 
with and without continuity correction (default value of 
0.5) as sensitivity analysis. Results were visualized using 
forest and network plots [10–13]. Statistical analysis was 
performed by experienced statistician (KM) in R 3.3.2 (R 
Core Team (2017). R: A  language and environment for 
statistical computing. R Foundation for Statistical Com-
puting, Vienna, Austria.) using the packages “meta” 4.9–
2 “metafor” 2.0-0 and “netmeta” 0.9–8 as well as Review 
Manager [14]. P-values less than 0.05 were considered to 
indicate statistical significance.
Results
The search revealed 22 papers (21 in English and 
1 in German). Nine papers were excluded from further 
analysis because they were review articles. Altogether 
13 full papers were evaluated by the authors for po-
tential meta-analysis. In total, three studies were final-
ly included in this meta-analysis (Tables I, II). The three 
studies that were analyzed included 2673 patients and 
observed 42 patients with immediate bleeding events 
(1.59%). All these events were minor bleeding complica-
tions. Numerical data used for this meta-analysis were 
extracted and retrieved from the final PDF versions of all 
3 papers (tables and text) and were available for all evalu-
ated subgroups. Each of the analyzed studies included all 
considered arms; hence head-to-head comparisons were 
possible. Without applying continuity correction the anal-
ysis showed that patients receiving SAPT with clopido-
grel and DAPT with ASA and clopidogrel had significantly 
greater odds for bleeding than the control patients. Such 
a result was not observed in terms of SAPT with ASA (Fig-
ure 2). Applying the continuity correction the result holds 
for and DAPT with ASA and clopidogrel only. The odds for 
SAPT with ASA as well as SAPT with clopidogrel were not 
significant when compared to the control group (Figure 3). 
The overall heterogeneity was significant with p-value 
for Cochrane’s Q test of 0.0002. As compared to the con-
trol group, the use of DAPT was associated with on OR of 
40.23 (95% CI: 4.37–370.36) increase in risk of bleeding 
events occurrence (p = 0.0011). Significant heterogeneity 
was observed (p < 0.001; I2 of 76.7%).
Discussion
The key finding of this meta-analysis is that there 
seems to be a significant increase in local bleeding com-
plications in patients undergoing dental extractions 
treated with double antiplatelet therapy with ASA and 
clopidogrel in comparison to controls, which is contradic-
tory to previously published results, which however were 
each time based on a small sample [9, 15–18]. 
Figure 1. PRISMA 2009 Flow Diagram
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There is a limited amount of published data concern-
ing the topic of our analysis. The studies which are avail-
able are only observational prospective and retrospective 
samples of patients. On the other hand, even though our 
sample comprised over 2000 cases, the overall observed 
incidence rate of local immediate bleeding complications 
was very low (1.6%). A  recently published meta-analy-
sis concluded similarly that DAPT vs placebo carries ad-
ditional risk for postoperative bleeding [19]. The main 
difference with our analysis is the inclusion of studies 
with various outcome measures defining bleeding. We 
also used only studies with direct SAPT, DAPT and control 
group comparisons. 
Even though the majority of available observational 
data seem to support the safety of dental extractions in 
antiplatelet regimes, many dentists still fear the effect 
the antiplatelet therapy may have on bleeding compli-
cations [20, 21]. It is vital for the community of cardiol-
ogists to provide evidence-based recommendations for 
dentists (e.g. review or meta-analysis of existing data) in 
order to diminish the practice of possible discontinuation 
of DAPT or SAPT for dental extractions [7]. On the other 
hand, with the introduction of new, more potent anti-
platelet drugs such as prasugrel and ticagrelor there is 
only one direct comparison in dental extractions, which 
revealed that prasugrel was associated with a consider-
ably longer bleeding time than clopidogrel [22]. A recent 
study, which was not included in the meta-analysis due 
to conflicting outcome definitions, concluded that using 
ticagrelor as part of DAPT does not increase the bleeding 
risk after extraction [23].
In our opinion based on the published data and the 
results of this meta-analysis, the crucial factor influ-
encing potential bleeding complications is not the an-
tiplatelet therapy itself (no platelet testing for its real 
efficacy in the discussed papers was evaluated) but the 
extraction procedure and the management of the wound 
[5, 7, 8]. The operators’ skills and following strict dental 
Table I. Papers included in the meta-analysis
Author Study type IRB approval Funding Groups Outcome
Lillis et al. Prospective 
observational
Yes None reported SAPT with ASA, SAPT with 
clopidogrel, DAPT, Controls
Lockhart definition of bleed-
ing applied [11]
Lu et al. Retrospective 
registry
Yes The study was supported 
in part by a CMRP research 
grant from the Chang 
Gung Memorial Hospital, 
Kaohsiung, Taiwan (CMRP-
G8C0642)
SAPT with ASA, SAPT with 
clopidogrel, DAPT, Controls
Immediate bleeding defini-
tion based on Lockhart [11]
Bajkin et al.* Prospective 
observational
Yes None reported SAPT with ASA, SAPT with 
clopidogrel, DAPT, Controls
Lockhart definition of bleed-
ing applied [11]
*Patients with ticlopidine (not recommended by guidelines anymore) and prasugrel (only 2 cases) were not included in the analysis. SAPT – single antiplatelet ther-
apy, ASA – acetylsalicylic acid, DAPT – dual antiplatelet therapy.
Table II. Results of selected trials
Study Group Number of patients 
with bleeding
Total number  
of patients
Percentage of patients 
with events (%)
OR (95% CI) vs. control*
Lu et al. SAPT ASA 2 185 1.1 1.60 (0.3474–7.3491)
SAPT clopidogrel 2 65 3.1 4.64 (0.9960–21.6277)
DAPT 1 24 4.2 6.36 (0.7811–51.7263)
Control 10 1472 0.7 –
Lillis et al. SAPT ASA 1 42 2.4 6.46 (0.5739–72.7878)
SAPT clopidogrel 1 36 2.8 7.57 (0.6701–85.5487)
DAPT 22 33 66.7 530 (110.7251–2536.9137)
Control 2 532 0.4 –
Bajkin et al. SAPT ASA 0 84 0.0 1.25 (0.0245–63.5811)^
SAPT clopidogrel 0 20 0.0 5.15 (0.0993–266.8422)^
DAPT 1 39 2.6 8.22 (0.3279–206.1241)
Control 0 105 0.0 –
*Adjusted for pairwise comparisons; ^with continuity correction.
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algorithms to minimize the risk of bleeding (gauze pads, 
thrombin, sutures etc.) irrespective of the concomitant 
antiplatelet therapy play a key role in the success of den-
tal extractions and preventing bleeding complications. It 
is also worth noting that the observed bleeding events 
were minor and did not carry additional risk for patients’ 
safety in all 3 papers included in the meta-analysis.
In order to minimize publication and data bias, we 
included in the meta-analysis only papers with a homo-
geneous outcome and clear extraction procedure descrip-
tions and definitions. Only papers with all inter-group 
comparisons available with control groups were included 
in the meta-analysis. Statistical measures were under-
taken so as to minimize the heterogeneity of the data. 
However, the small number of trials made it impossible 
to construct informative funnel plots and the test for 
symmetry was not performed following the recommen-
dation by Sterne et al. [24].
Figure 2. Intergroup comparisons performed in the meta-analysis
Study or           SAPT ASA           Control  Weight  Odds ratio Odds ratio
subgroup Events Total Events Total (%) M-H, fixed, 95% CI M-H, fixed, 95% CI
Bajkin et al. 0 84 0 105  Not estimable 
Lillis et al. 1 42 2 532 11.5 6.46 (0.57–72.79) 
Lu et al. 2 185 10 1472 88.5 1.60 (0.35–7.35) 
Total (95% CI)  311  2109 100.0 2.16 (0.61–7.65) 
Total events 3  12
Heterogeneity: c2 = 0.94, df = 1 (p = 0.33), I2 = 0%
Test for overall effect Z = 1.19 (p = 0.23)
Study or            DAPT             Control  Weight  Odds ratio Odds ratio
subgroup Events Total Events Total (%) M-H, random, 95% CI M-H, random, 95% CI
Bajkin et al. 1 39 0 105 28.8 8.22 (0.33–206.12) 
Lillis et al. 22 33 2 532 36.7 530.00 (110.73–2536.91) 
Lu et al. 1 24 10 1472 34.4 6.36 (0.78–51.73) 
Total (95% CI)  96  2109 100.0 34.77 (1.33–906.16) 
Total events 24  12
Heterogeneity: t2 = 6.89, c2 = 13.15, df = 2 (p = 0.001), I2 = 85%
Test for overall effect Z = 2.13 (p = 0.03)
Study or     SAPT clopidogrel       Control  Weight  Odds ratio Odds ratio
subgroup Events Total Events Total (%) M-H, fixed, 95% CI M-H, fixed, 95% CI
Bajkin et al. 0 20 0 105  Not estimable 
Lillis et al. 1 36 2 532 23.1 7.57 (0.67–85.55) 
Lu et al. 2 65 10 1472 76.9 4.64 (1.00–21.63) 
Total (95% CI)  121  2109 100.0 5.32 (1.47–19.30) 
Total events 3  12
Heterogeneity: c2 = 0.11, df = 1 (p = 0.74), I2 = 0%
Test for overall effect Z = 2.54 (p = 0.01)
 0.01 0.1 1 10 100
  Favours (SAPT ASA)  Favours (Control)
 0.001 0.1 1 10 100
  Favours (DAPT)  Favours (Control)
 0.01 0.1 1 10 100
  Favours (SAPT clopidogrel)  Favours (Control)
Antiplatelet therapy Odds ratio (95% CI) 
Control 1.00 (1.00–1.00)
SAPT ASA 2.41 (0.24–24.78)
SAPT clopidogrel 5.62 (0.55–57.87)
DAPT 40.23 (4.37–370.36) 
Figure 3. Meta-analysis results presented as OR and 95% CI in controls vs. SAPT or DAPT
 0.1 0.2 0.4 1.0 2.0 4.0 7.0 20.0 40.0 100.0 500.0
Odds ratio for antiplatelet therapy vs. control
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The main limitation of this analysis is the lack of ran-
domized clinical trials which could be included in the me-
ta-analysis. However, in the face of a lack of randomized 
data we felt it is reasonable to investigate the existing 
data. It is also troublesome to pool published data since 
different outcome measures are applied in various pa-
pers. It also seems that the baseline profile of patients 
may play a potential role in the incidence of bleeding, e.g. 
the frequency of renal failure [18]. We tried to minimize 
this bias and finally included 3 papers so as to follow 
strict inclusion/exclusion criteria and similar outcome 
measures used in each manuscript.
Conclusions
Dental extractions following strict procedural proto-
cols in patients on double antiplatelet therapy with clopi-
dogrel and ASA are associated with an additional risk of 
immediate local bleeding complications. Based on our 
results there seems to be no controversy over the safe-
ty of dental extraction on SAPT. However, new studies 
with prasugrel and ticagrelor are desired in order to con-
firm the effect also in the new generation of antiplatelet 
agents, preferably in a randomized manner. 
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